|
||||||
Executive Summary ProMetic Life Sciences Inc.-Product Pipeline Review-2015 Summary Global Markets Direct's, 'ProMetic Life Sciences Inc.-Product Pipeline Review-2015', provides an overview of the ProMetic Life Sciences Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ProMetic Life Sciences Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides brief overview of ProMetic Life Sciences Inc. including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of ProMetic Life Sciences Inc.'s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the ProMetic Life Sciences Inc.'s pipeline products Reasons To Buy Evaluate ProMetic Life Sciences Inc.'s strategic position with total access to detailed information on its product pipeline Assess the growth potential of ProMetic Life Sciences Inc. in its therapy areas of focus Identify new drug targets and therapeutic classes in the ProMetic Life Sciences Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of ProMetic Life Sciences Inc. and exploit collaboration and partnership opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying the most promising pipeline of ProMetic Life Sciences Inc. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of ProMetic Life Sciences Inc. and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 ProMetic Life Sciences Inc. Snapshot 5 ProMetic Life Sciences Inc. Overview 5 Key Information 5 Key Facts 5 ProMetic Life Sciences Inc.-Research and Development Overview 6 Key Therapeutic Areas 6 ProMetic Life Sciences Inc.-Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products-Monotherapy 10 ProMetic Life Sciences Inc.-Pipeline Products Glance 11 ProMetic Life Sciences Inc.-Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 ProMetic Life Sciences Inc.-Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 ProMetic Life Sciences Inc.-Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 ProMetic Life Sciences Inc.-Drug Profiles 15 immune globulin (human) 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 PBI-1402 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 PBI-4050 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 plasminogen (human) 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 alpha-1 proteinase inhibitor (human) 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 PBI-0110 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 PBI-1393 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 PBI-1522 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 PBI-1668 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 PBI-1737 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 PBI-4419 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 PBI-4494 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 PBI-4547 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 ProMetic Life Sciences Inc.-Pipeline Analysis 30 ProMetic Life Sciences Inc.-Pipeline Products by Target 30 ProMetic Life Sciences Inc.-Pipeline Products by Route of Administration 31 ProMetic Life Sciences Inc.-Pipeline Products by Molecule Type 32 ProMetic Life Sciences Inc.-Pipeline Products by Mechanism of Action 33 ProMetic Life Sciences Inc.-Recent Pipeline Updates 34 ProMetic Life Sciences Inc.-Dormant Projects 38 ProMetic Life Sciences Inc.-Locations And Subsidiaries 39 Head Office 39 Other Locations & Subsidiaries 39 Appendix 41 Methodology 41 Coverage 41 Secondary Research 41 Primary Research 41 Expert Panel Validation 41 Contact Us 41 Disclaimer 42 List of Tables ProMetic Life Sciences Inc., Key Information 5 ProMetic Life Sciences Inc., Key Facts 5 ProMetic Life Sciences Inc.-Pipeline by Indication, 2015 7 ProMetic Life Sciences Inc.-Pipeline by Stage of Development, 2015 9 ProMetic Life Sciences Inc.-Monotherapy Products in Pipeline, 2015 10 ProMetic Life Sciences Inc.-Phase III, 2015 11 ProMetic Life Sciences Inc.-Phase II, 2015 12 ProMetic Life Sciences Inc.-Phase I, 2015 13 ProMetic Life Sciences Inc.-Preclinical, 2015 14 ProMetic Life Sciences Inc.-Pipeline by Target, 2015 30 ProMetic Life Sciences Inc.-Pipeline by Route of Administration, 2015 31 ProMetic Life Sciences Inc.-Pipeline by Molecule Type, 2015 32 ProMetic Life Sciences Inc.-Pipeline Products by Mechanism of Action, 2015 33 ProMetic Life Sciences Inc.-Recent Pipeline Updates, 2015 34 ProMetic Life Sciences Inc.-Dormant Developmental Projects,2015 38 ProMetic Life Sciences Inc., Other Locations 39 ProMetic Life Sciences Inc., Subsidiaries 40 List of Figures ProMetic Life Sciences Inc.-Pipeline by Top 10 Indication, 2015 7 ProMetic Life Sciences Inc.-Pipeline by Stage of Development, 2015 9 ProMetic Life Sciences Inc.-Monotherapy Products in Pipeline, 2015 10 ProMetic Life Sciences Inc.-Pipeline by Top 10 Target, 2015 30 ProMetic Life Sciences Inc.-Pipeline by Top 10 Route of Administration, 2015 31 ProMetic Life Sciences Inc.-Pipeline by Top 10 Molecule Type, 2015 32 ProMetic Life Sciences Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 33 Single User License: Site License: Corporate User License: Current R&D Portfolio of ProMetic Life Sciences Inc.; ProMetic Life Sciences Inc. - Key Therapeutics; ProMetic Life Sciences Inc. - Pipeline Overview and Promising Molecules; ProMetic Life Sciences Inc. - News; ProMetic Life Sciences Inc. - Latest Updates; ProMetic Life Sciences Inc. - Pipeline; ProMetic Life Sciences Inc. - Discontinued/Dormant Projects |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center" |